Fulcrum Therapeutics's total assets for Q4 2024 were $242.65M, a decrease of -6.93% from the previous quarter. FULC total liabilities were $14.16M for the fiscal quarter, a -19.91% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.